Bipartisan Legislators Circulate Letter Asking FDA to Back Off CBD Firms

September 18, 2019 15:00:43

A pair of bipartisan legislators is circulating a letter asking for the support of their colleagues in calling on the U.S. Food and Drug Administration (FDA) to back off the CBD companies that are conducting business in a responsible manner.

This effort is being spearheaded by Reps. James Corner (R-KY) and Chellie Pingree (D-ME). Their letter stresses that CBD and hemp were legalized in 2018 and the current lack of regulations is creating uncertainty and stifling economic opportunities within…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office